Cleared Traditional

K922218 - IQ SYSTEM

K922218 is an FDA 510(k) clearance for IQ SYSTEM, manufactured by Renaissance Technology, Inc.. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 210-day FDA review.

K922218 · Renaissance Technology, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1992
Decision
210d
Days
Class 2
Risk

K922218 is an FDA 510(k) clearance for the IQ SYSTEM. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Renaissance Technology, Inc. (Newtown, US). The FDA issued a Cleared decision on December 8, 1992 after a review of 210 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Renaissance Technology, Inc. devices

FDA 510(k) Submission Details - K922218

510(k) Number K922218 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 1992
Decision Date December 08, 1992
Days to Decision 210 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
85d slower than avg
Panel avg: 125d · This submission: 210d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 97
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K922218.
HORIZON 9000 WS
K940415 · Mennen Medical, Inc. · Jan 1995
CARDIAC OUTPUT OPTION 39
K943256 · Medical Data Electronics · Dec 1994
CONTINUOUS CARDIAC OUTPUT SYSTEM
K932414 · Abbott Laboratories · Nov 1994
MIDAS SYSTEM(TM) 5100 PHYSIOLOG MONIT/RECORD SYST
K913358 · Ppg Industries, Inc. · Dec 1991
CARDIAC OUTPUT COMPUTER, MODEL COM-3
K896930 · Baxter Healthcare Corp · Jul 1990
NOVA MICROSONICS DATAVUE ECHO ANALYSIS SYSTEM
K897004 · Advanced Technology Laboratories, Inc. · Mar 1990